Our reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

The anti-hypertensive drugs market is forecasted to achieve high growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 3%, as per The Business Research Company’s market report!

Read More On The Anti-Hypertensive Drugs Market Report 2022 – https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

The Anti-Hypertensive Drugs Market Size In 2022 And Forecast

The global anti-hypertensive drugs market is expected to grow from $35.61 billion in 2021 to $37.47 billion in 2022 at a compound annual growth rate (CAGR) of 5.2%. The growth in the anti-hypertensive drugs market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global anti-hypertensive drug market size is expected to reach $42.85 billion in 2026 at a CAGR of 3.4%.

The anti-hypertensive drugs market consists of sales of anti-hypertensive drugs and related services.

Request for A Sample Of The Global Anti-Hypertensive Drugs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

Sedentary Lifestyle Is Driving The Growth Of The Anti-Hypertensive Drugs Market

Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed of hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the anti-hypertensive drugs market.

Competitive Landscape And The Regional Analysis Of The Anti-Hypertensive Drugs Market

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA, United Therapeutics, Ranbaxy Laboratories, Bayer AG, Lupin Limited, Boehringer Engelheim GmbH, Sun Pharmaceuticals LLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Roche, Abbott, Gilead, Actelion, and Teva Pharmaceutical Industries Ltd.

Additionally, as per TBRC’s research – North America was the largest region in the anti-hypertensive drugs market in 2021 holding the largest market share and The Middle East is expected to be the fastest-growing region in the forecast period.

The Anti-Hypertensive Drugs Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the anti-hypertensive drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the anti-hypertensive drugs market.

Combination Therapies – A Key Trend In The Anti-Hypertensive Drugs Market

Of late, there has been rise in use of combination therapies compared to monotherapy treatment. Monotherapy is the treatment of a hypertension with a single drug, while the use of combinations of drugs (Combination Therapy) allows for action on several different hypertensive mechanisms. When the two drugs are combined with different mechanisms of action, the effect is two to five times greater than monotherapy. Increasing the dose of monotherapy reduces coronary events by 29% and cerebrovascular events by 40%, while combining two antihypertensive agents with a different mechanism of action reduces coronary events by 40% and cerebrovascular events by 54%. Thus, the use of combination therapy provides greater protection to a target organ than increasing the dose of monotherapy. The trend of using combination therapy is thus more effective and is being widely accepted as well.

Anti-Hypertensive Drugs Market Segmentation By The Business Research Company

1) By Therapeutic: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End-User: Hospitals, Clinics, Homecare

Here Are Some Reports Related To The Anti-Hypertensive Drugs Market –

Diuretics Global Market Report 2022

Pharmaceutical Drugs Global Market Report 2022

Pharmaceuticals Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: